Mpox Vaccines and ‘Emergency Use’ Authorization Explained.

mpox Vaccine EUAs On November 28, 2022, the World Health Organization announced, and the U.S. government supported, renaming monkeypox disease to mpox. In response to this action...

Smart for Life (SMFL) Announces Letter of Intent to Acquire Largest Acquisition to Date.

6th Acquisition to Date is Expected to Add over $15 million of Revenue and to be Accretive to Earnings. Stated goal of $100 million in...

Revive (RVVTF) Hits a Snag?

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 First our summary."FDA provided communication that the amended protocol is still under...

Revive Therapeutics (RVVTF) Annual Shareholder Meeting.

ANNUAL SHAREHOLDER MEETING https://vimeo.com/752050831 CORPORATE PRESENTATION | AUGUST 2022 NEWS ARCHIVE

13 Keys to a Successful FDA Advisory Committee Meeting (Regulatory Focus)

RAPS' Latest | 01 August 2019 | By Zachary Brousseau  When the US Food and Drug Administration (FDA) has significant questions or concerns about clinical data...

Adding Progressive Care (RXMD) $0.04 to Watch List.

Adding to Biotech Stock Review 2022 Watch List. Speculative, Yes. But Pay Down of $2 Million Toxic Note and Move into Remote Patient Monitoring Makes...

CB Scientific, Inc. (CBSC) Announces FDA 510(k) Submission.

CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor Updated product to include significant operating improvements and material design advances over...

Provention Bio (PRVB) Announces $125 Million Term Loan Facility with Hercules Capital

Don't think we've ever seen anything like this before. Most investors who prefer to invest post FDA approval, invest post FDA approval. They got...

Is There Enough Monkeypox (Mpox) Vaccine to go Around? Maybe yes, More Likely no.

Reported in Gates and Soda As monkeypox cases continue to mount – topping 31,000 cases globally – governments of wealthy nations have been scrambling to...
Dr John Fahy UCSF

Revive Therapeutics (RVVTF) Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company...

Latest article

GeoVax (GOVX) Conference Call and Transcript.

Excellent Presentation. You Can Listen for 40 Minutes, or Read it in About Ten, Halleluiah. Guess what we'll choose to do? For the life...

Sekur Private Data (SWISF) Awarded Distribution Agreement With Elyon International.

Top Ranked Defense, Government and Enterprise Contractor Trying to Break Over $0.06. We are still sitting on the edge of our seat waiting for contract news,...

Broker Dealer – AtlasClear (ATCH) Conference Call

"AtlasClear is being built as an integrated financial services platform that will bring capital markets origination, clearing, and banking together under a single architecture."...